Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Frontiers in Pharmacology|July 31, 2023
Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer's diseaseSunil Thomas, George C PrendergastMethods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Cancer Vaccines: A Brief OverviewSunil Thomas, George C PrendergastPlos One|November 2, 2022
Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatmentSunil Thomas, Giancarlo Mercogliano, George C PrendergastMethods in Enzymology|November 16, 2019
Reliable detection of indoleamine 2,3 dioxygenase-1 in murine cells and tissuesSunil Thomas, Lisa Laury-Kleintop, George C PrendergastCancer Journal (Sudbury, Mass.)|January 24, 2023
A Brief Overview of Cancer VaccinesAlexander J Muller, Sunil Thomas, George C PrendergastJournal of Cellular Biochemistry|June 19, 2019
Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's diseaseSunil Thomas, Kevther Hoxha, Allison Tran, et al.Journal of Cellular Biochemistry|October 15, 2013
Specific in situ detection of murine indoleamine 2, 3-dioxygenaseSunil Thomas, James DuHadaway, George C Prendergast, et al.Scientific Reports|July 21, 2023
Diet effects on colonic health influence the efficacy of Bin1 mAb immunotherapy for ulcerative colitisSunil Thomas, Nickey Dilbarov, Joseph Kelly, et al.Digestive Diseases and Sciences|July 22, 2015
Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier FunctionSunil Thomas, Joanna M Mercado, James DuHadaway, et al.Cancer Research|March 17, 2011
Perspectives on emerging trends in cancer researchGeorge C PrendergastPageof 23